Gene-targeting therapies for AML

From the 2018 Society of Hematologic Oncology (SOHO) Annual Meeting in Houston, TX, Harry Erba of Duke University, Durham, NC, discusses the recently approved enasidenib and ivosidenib, which target I... Author: VJHemOnc Added: 09/28/2018
Source: Oncology Tube - Category: Cancer & Oncology Source Type: podcasts